SEC Tracker
Get the app
VTRS · XBRL financial data

Viatris financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (VTRS's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue3,837*3,6633,7973,7513,528*3,2543,5823,7603,704*3,5173,7573,750
Revenue from contracts with customers3,826*3,6543,7863,7383,515*3,2433,5693,7483,691*3,5103,7463,735
Cost of goods and services sold2,241*2,1592,3512,2922,313*2,0932,2492,3882,556*2,3602,3002,312
Gross profit1,597*1,5041,4451,4591,215*1,1611,3331,3721,148*1,1571,4571,438
Research and development—200204198—222219250—249248232
Selling, general and administrative1,606*1,0181,3581,0031,047*9489298871,031*9291,135951
Total operating expenses2,051*1,3001,6851,2331,395*4,0431,1001,1931,341*1,2371,4501,177
Operating income (loss)(455)*204(240)226(180)*(2,882)233179(193)*(80)6262
Interest expense141*138146146120*116117120120*120121112
Other income (expense)(260)*139(6)10(227)*(99)(334)(67)(31)*(48)50(21)
Income tax expense (benefit)(89)*91(65)(4)(10)*(55)(213)120(3)*(424)55453
Earnings per share, basic USD per share—0.10(0.27)0.08—(2.55)0.00(0.11)—0.15(0.10)(0.28)
Earnings per share, diluted USD per share—0.09(0.27)0.08—(2.55)0.00(0.11)—0.15(0.10)(0.28)
Weighted average shares, basic millions of shares1,200*1,1951,1911,194—1,1921,1731,165—1,1551,1631,149
Weighted average shares, diluted millions of shares1,211*1,2101,1911,200—1,1921,1731,165—1,1751,1631,149

Balance sheet

CSV

Fiscal quarters (VTRS's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents9921,0159171,8797357555669751,3221,8048871,789
Marketable securities37———38———41———
Accounts receivable3,7003,6323,5673,7173,2213,1263,2583,3723,0313,0763,1263,121
Inventory3,4703,8233,9424,0853,8544,0964,2644,1113,9993,9273,9333,829
Prepaid and other current assets2,0281,9331,7571,6271,7111,6451,6861,4931,4362,1092,1101,558
Total current assets12,97612,92411,79211,3089,5219,6229,7759,9519,78910,91710,05610,298
Property and equipment, net2,7602,7082,6632,6772,6662,6362,6432,6262,6142,5282,4402,420
Right-of-use asset246242273268253266276266271253259251
Goodwill9,8679,6949,3269,5629,1336,4626,7486,7316,7556,6926,6546,620
Total assets47,68647,34445,33044,75441,50138,47538,41237,92037,19336,83535,04534,683
Current portion of long-term debt1,9431,8982,3671,447891,6811,9521,9331,9311,7391,728
Total current liabilities7,7777,7607,7097,5125,7795,7207,1337,3647,0946,8106,3466,637
Long-term debt16,18816,07314,73114,30314,03914,17812,79212,48812,48112,41411,61211,588
Lease liability, non-current165156192188179177182171178167160154
Total liabilities27,21827,32925,81024,96222,86522,82522,84122,70322,48222,17720,78420,997
Retained earnings (accumulated deficit)4,6404,6084,1344,0823,41922880(48)(388)(212)(331)(656)
Total liabilities and equity47,68647,34445,33044,75441,50138,47538,41237,92037,19336,83535,04534,683
Common shares outstanding (cover page) millions of shares1,1881,1911,1941,1941,1941,1741,1661,1521,1511,1651,1491,146

Cash flows

CSV

Fiscal quarters (VTRS's year ends in late December)

In millions of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Stock-based compensation56*4735*32*32*5537*36*49*4839*40*
Depreciation and amortization644*691786*670*746*665678*689*767*676672*697*
Net cash from operating activities479*615379*827*483*536220*745*816*388382*899*
Purchases of property and equipment166*5059*77*140*4353*87*197*4053*86*
Net cash from investing activities116*(154)376*1,748*(169)*(65)(53)*(99)*(211)*277(52)*292*
Proceeds from issuing common stock1*11*1*1*11*1*1*11*1*
Share repurchases0*2500*0*0*1751756885*0150*150
Proceeds from long-term debt0*———year only——0*0*——0*
Repayments of long-term debt500*0802*1,538*1,374*——0*0*——0*
Net cash from financing activities(926)*(426)(848)*(1,637)*(1,420)*(467)(362)*(228)*(236)*(204)(1,243)*(290)*
Net change in cash(318)*22(97)*962*(1,144)*20(189)*436*345*458(916)*903*

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Viatris1,7893,735899*1.1B— 10-QSep 30, 2026
Roivant Sciences1,2481.4(271)722.3M14.2 quarters 10-QJun 30, 2026
United Therapeutics1,189833307*42.6M— 10-QSep 30, 2026
Neurocrine Biosciences6421,123395*101.2M— 10-QSep 30, 2026
Exelixis305659280*244.0M— 10-QOct 2, 2026
BIO-TECHNE265321*95*156.8M— 10-KJun 30, 2026
BeOne Medicines5,7811,890509*1.5B— 10-QSep 30, 2026
Biomarin Pharmaceutical7361,025188*193.7M— 10-QSep 30, 2026
Revolution Medicines616198(416)*216.3M9.4 quarters 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.